Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Multicentric Study of Digoxin Per os in Classic or Endemic Kaposi' s Sarcoma

NCT02212639 is registered in ClinicalTrials.gov with Assistance Publique - Hôpitaux de Paris as lead sponsor.

NCT NCT02212639
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02212639 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Multicentric Study of Digoxin Per os in Classic or Endemic Kaposi' s Sarcoma
Lead sponsor
Assistance Publique - Hôpitaux de Paris
Phase
Phase 2
Overall status
Unknown status
Start date
September 30, 2014
Completion date
September 30, 2019
Enrollment
17 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

classic kaposi' s sarcoma, endemic kaposi' s sarcoma, kaposi' s sarcoma, lymph angio proliferations